Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.

Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.

Europace. 2011 Feb;13(2):174-81. doi: 10.1093/europace/euq386. Epub 2010 Nov 8.

PMID:
21059740
2.

Lack of effect of statins on maintenance of normal sinus rhythm following electrical cardioversion of persistent atrial fibrillation.

Bhardwaj A, Sood NA, Kluger J, Coleman CI.

Int J Clin Pract. 2010 Jul;64(8):1116-20. doi: 10.1111/j.1742-1241.2010.02387.x. Review.

PMID:
20642710
3.

Omega-3 fatty acids in the prevention of atrial fibrillation recurrences after cardioversion: a meta-analysis of randomized controlled trials.

Cao H, Wang X, Huang H, Ying SZ, Gu YW, Wang T, Huang CX.

Intern Med. 2012;51(18):2503-8. Epub 2012 Sep 15. Review.

4.

[Atrial fibrillation: always cardioversion? No].

Di Pasquale G, Biancoli S, Sassone B, Pancaldi LG.

Ital Heart J Suppl. 2002 Jan;3(1):81-90. Review. Italian.

PMID:
11899578
5.

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.

Mariani J, Doval HC, Nul D, Varini S, Grancelli H, Ferrante D, Tognoni G, Macchia A.

J Am Heart Assoc. 2013 Feb 19;2(1):e005033. doi: 10.1161/JAHA.112.005033. Review.

6.

Omega-3 fatty acids and cardiac arrhythmias.

Rix TA, Christensen JH, Schmidt EB.

Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):168-73. doi: 10.1097/MCO.0b013e32835bf39b. Review.

PMID:
23196815
7.

The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.

Billman GE.

Pharmacol Ther. 2013 Oct;140(1):53-80. doi: 10.1016/j.pharmthera.2013.05.011. Epub 2013 Jun 2. Review.

PMID:
23735203
8.

Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials.

Armaganijan L, Lopes RD, Healey JS, Piccini JP, Nair GM, Morillo CA.

Clinics (Sao Paulo). 2011;66(11):1923-8. Review.

9.

Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.

Li TJ, Zang WD, Chen YL, Geng N, Ma SM, Li XD.

Int J Clin Pract. 2013 Jun;67(6):536-43. doi: 10.1111/ijcp.12063. Epub 2013 Apr 5. Review.

PMID:
23557493
10.

Role of omega-3 fatty acids in the prevention of atrial fibrillation.

Kar S.

Rev Cardiovasc Med. 2013;14(2-4):e82-91. Review.

PMID:
24448258
11.

The anti-arrhythmic effects of n-3 PUFAs.

Calò L, Martino A, Tota C.

Int J Cardiol. 2013 Dec 20;170(2 Suppl 1):S21-7. doi: 10.1016/j.ijcard.2013.06.043. Epub 2013 Sep 6. Review.

PMID:
24016540
12.

Predictors of long-term maintenance of normal sinus rhythm after successful electrical cardioversion.

Abu-El-Haija B, Giudici MC.

Clin Cardiol. 2014 Jun;37(6):381-5. doi: 10.1002/clc.22276. Epub 2014 Apr 3. Review.

13.

The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation.

Christou GA, Christou KA, Korantzopoulos P, Rizos EC, Nikas DN, Goudevenos JA.

Int J Mol Sci. 2015 Sep 22;16(9):22870-87. doi: 10.3390/ijms160922870. Review.

14.

Omega-3 fatty acid: a role in the management of cardiac arrhythmias?

Cheng JW, Santoni F.

J Altern Complement Med. 2008 Oct;14(8):965-74. doi: 10.1089/acm.2007.0765. Review.

PMID:
18928392
15.

Omega-3 PUFAs and atrial fibrillation: have we made up our mind yet?

Guerra F, Shkoza M, Scappini L, Roberti L, Capucci A.

Ann Noninvasive Electrocardiol. 2013 Jan;18(1):12-20. doi: 10.1111/anec.12020. Epub 2012 Nov 22. Review.

PMID:
23347022
16.

The current role of statin therapy in the treatment of atrial fibrillation.

Naji F, Sabovic M.

Cardiovasc Hematol Agents Med Chem. 2013 Mar;11(1):9-13. Review.

PMID:
22856623
17.

Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.

Nodari S, Triggiani M, Campia U, Dei Cas L.

J Atr Fibrillation. 2012 Dec 16;5(4):718. doi: 10.4022/jafib.718. eCollection 2012 Dec. Review.

18.

Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.

Patel JV, Tracey I, Hughes EA, Lip GY.

Vasc Health Risk Manag. 2009;5:801-10. Epub 2009 Sep 24. Review.

19.

Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western countries to Japan.

Sekikawa A, Doyle MF, Kuller LH.

Trends Cardiovasc Med. 2015 Nov;25(8):717-23. doi: 10.1016/j.tcm.2015.03.001. Epub 2015 Mar 6. Review.

PMID:
25850978
20.

Diet and risk of atrial fibrillation – epidemiologic and clinical evidence –.

Gronroos NN, Alonso A.

Circ J. 2010 Oct;74(10):2029-38. Epub 2010 Sep 11. Review.

Supplemental Content

Support Center